cloudfront
  • info@reportsandmarkets.com
  • +44-020-3286-9338 (UK) | +1-214-736-7666 (US) | +1-740-994-0111 (US)
  • Sign In
  • Register

Report Detail



OtherGlobal Antifungal infection Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • RnM2541261
  • |
  • 9 November, 2018
  • |
  • Global
  • |
  • 136 pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

Antifungal drugs are used to treat infections caused by fungus and to prevent the development of fungal infections in patients with weakened immune systems.

Scope of the Report:

The global Antifungal infection Therapeutics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Antifungal infection Therapeutics.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

This report studies the Antifungal infection Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Antifungal infection Therapeutics market by product type and applications/end industries.

Market Segment by Companies, this report covers

Scynexis

Sanofi-Aventis

Pfizer

Novartis

Merck & Co

Kramer Laboratories

Johnson & Johnson

ID Sigma-Aldrich Corporation

Glenmark Pharmaceuticals

Glaxosmithkline

Enzon Pharmaceuticals

Bayer Healthcare

Astellas Pharma

Asperqillus

Alternaria

Abbott Laboratories

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Polyenes

Echinocandins

Azoles

Allylamines

Other Drug types

Market Segment by Applications, can be divided into

Powders

Pastes

Ointments

Drugs

Other Applications


Table of Contents

1 Antifungal infection Therapeutics Market Overview

1.1 Product Overview and Scope of Antifungal infection Therapeutics

1.2 Classification of Antifungal infection Therapeutics by Types

1.2.1 Global Antifungal infection Therapeutics Revenue Comparison by Types (2017-2023)

1.2.2 Global Antifungal infection Therapeutics Revenue Market Share by Types in 2017

1.2.3 Polyenes

1.2.4 Echinocandins

1.2.5 Azoles

1.2.6 Allylamines

1.2.7 Other Drug types

1.3 Global Antifungal infection Therapeutics Market by Application

1.3.1 Global Antifungal infection Therapeutics Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Powders

1.3.3 Pastes

1.3.4 Ointments

1.3.5 Drugs

1.3.6 Other Applications

1.4 Global Antifungal infection Therapeutics Market by Regions

1.4.1 Global Antifungal infection Therapeutics Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Antifungal infection Therapeutics Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Antifungal infection Therapeutics Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Antifungal infection Therapeutics Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Antifungal infection Therapeutics Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Antifungal infection Therapeutics Status and Prospect (2013-2023)

1.5 Global Market Size of Antifungal infection Therapeutics (2013-2023)

2 Manufacturers Profiles

2.1 Scynexis

2.1.1 Business Overview

2.1.2 Antifungal infection Therapeutics Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Scynexis Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.2 Sanofi-Aventis

2.2.1 Business Overview

2.2.2 Antifungal infection Therapeutics Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Sanofi-Aventis Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.3 Pfizer

2.3.1 Business Overview

2.3.2 Antifungal infection Therapeutics Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Pfizer Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.4 Novartis

2.4.1 Business Overview

2.4.2 Antifungal infection Therapeutics Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Novartis Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.5 Merck & Co

2.5.1 Business Overview

2.5.2 Antifungal infection Therapeutics Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Merck & Co Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.6 Kramer Laboratories

2.6.1 Business Overview

2.6.2 Antifungal infection Therapeutics Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Kramer Laboratories Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.7 Johnson & Johnson

2.7.1 Business Overview

2.7.2 Antifungal infection Therapeutics Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Johnson & Johnson Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.8 ID Sigma-Aldrich Corporation

2.8.1 Business Overview

2.8.2 Antifungal infection Therapeutics Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 ID Sigma-Aldrich Corporation Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.9 Glenmark Pharmaceuticals

2.9.1 Business Overview

2.9.2 Antifungal infection Therapeutics Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Glenmark Pharmaceuticals Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.10 Glaxosmithkline

2.10.1 Business Overview

2.10.2 Antifungal infection Therapeutics Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Glaxosmithkline Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.11 Enzon Pharmaceuticals

2.11.1 Business Overview

2.11.2 Antifungal infection Therapeutics Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Enzon Pharmaceuticals Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.12 Bayer Healthcare

2.12.1 Business Overview

2.12.2 Antifungal infection Therapeutics Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Bayer Healthcare Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.13 Astellas Pharma

2.13.1 Business Overview

2.13.2 Antifungal infection Therapeutics Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Astellas Pharma Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.14 Asperqillus

2.14.1 Business Overview

2.14.2 Antifungal infection Therapeutics Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 Asperqillus Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.15 Alternaria

2.15.1 Business Overview

2.15.2 Antifungal infection Therapeutics Type and Applications

2.15.2.1 Product A

2.15.2.2 Product B

2.15.3 Alternaria Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.16 Abbott Laboratories

2.16.1 Business Overview

2.16.2 Antifungal infection Therapeutics Type and Applications

2.16.2.1 Product A

2.16.2.2 Product B

2.16.3 Abbott Laboratories Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

3 Global Antifungal infection Therapeutics Market Competition, by Players

3.1 Global Antifungal infection Therapeutics Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Antifungal infection Therapeutics Players Market Share

3.2.2 Top 10 Antifungal infection Therapeutics Players Market Share

3.3 Market Competition Trend

4 Global Antifungal infection Therapeutics Market Size by Regions

4.1 Global Antifungal infection Therapeutics Revenue and Market Share by Regions

4.2 North America Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

4.3 Europe Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

4.5 South America Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

5 North America Antifungal infection Therapeutics Revenue by Countries

5.1 North America Antifungal infection Therapeutics Revenue by Countries (2013-2018)

5.2 USA Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

5.3 Canada Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

5.4 Mexico Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

6 Europe Antifungal infection Therapeutics Revenue by Countries

6.1 Europe Antifungal infection Therapeutics Revenue by Countries (2013-2018)

6.2 Germany Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

6.3 UK Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

6.4 France Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

6.5 Russia Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

6.6 Italy Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Antifungal infection Therapeutics Revenue by Countries

7.1 Asia-Pacific Antifungal infection Therapeutics Revenue by Countries (2013-2018)

7.2 China Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

7.3 Japan Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

7.4 Korea Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

7.5 India Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

8 South America Antifungal infection Therapeutics Revenue by Countries

8.1 South America Antifungal infection Therapeutics Revenue by Countries (2013-2018)

8.2 Brazil Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

8.3 Argentina Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

8.4 Colombia Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Antifungal infection Therapeutics by Countries

9.1 Middle East and Africa Antifungal infection Therapeutics Revenue by Countries (2013-2018)

9.2 Saudi Arabia Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

9.3 UAE Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

9.4 Egypt Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

9.5 Nigeria Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

9.6 South Africa Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

10 Global Antifungal infection Therapeutics Market Segment by Type

10.1 Global Antifungal infection Therapeutics Revenue and Market Share by Type (2013-2018)

10.2 Global Antifungal infection Therapeutics Market Forecast by Type (2018-2023)

10.3 Polyenes Revenue Growth Rate (2013-2023)

10.4 Echinocandins Revenue Growth Rate (2013-2023)

10.5 Azoles Revenue Growth Rate (2013-2023)

10.6 Allylamines Revenue Growth Rate (2013-2023)

10.7 Other Drug types Revenue Growth Rate (2013-2023)

11 Global Antifungal infection Therapeutics Market Segment by Application

11.1 Global Antifungal infection Therapeutics Revenue Market Share by Application (2013-2018)

11.2 Antifungal infection Therapeutics Market Forecast by Application (2018-2023)

11.3 Powders Revenue Growth (2013-2018)

11.4 Pastes Revenue Growth (2013-2018)

11.5 Ointments Revenue Growth (2013-2018)

11.6 Drugs Revenue Growth (2013-2018)

11.7 Other Applications Revenue Growth (2013-2018)

12 Global Antifungal infection Therapeutics Market Size Forecast (2018-2023)

12.1 Global Antifungal infection Therapeutics Market Size Forecast (2018-2023)

12.2 Global Antifungal infection Therapeutics Market Forecast by Regions (2018-2023)

12.3 North America Antifungal infection Therapeutics Revenue Market Forecast (2018-2023)

12.4 Europe Antifungal infection Therapeutics Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Antifungal infection Therapeutics Revenue Market Forecast (2018-2023)

12.6 South America Antifungal infection Therapeutics Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Antifungal infection Therapeutics Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source


captcha
Enter the code in the box:


captcha
Enter the code in the box:

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may not print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.


captcha
Enter the code in the box:



Summary:
Get latest Market Research Reports on Antifungal infection Therapeutics . Industry analysis & Market Report on Antifungal infection Therapeutics is a syndicated market report, published as Global Antifungal infection Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023. It is complete Research Study and Industry Analysis of Antifungal infection Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,480.00
$5,220.00
$6,960.00
2,336.82
3,505.23
4,673.64
3,202.30
4,803.44
6,404.59
421,567.20
632,350.80
843,134.40
230,770.63
346,155.95
461,541.26
Add To Cart Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report